Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06454188 · ClinicalTrials.gov registry record · Phase 4

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

A Phase 4 study of Psoriatic Arthritis and Spondyloarthritis, Axial, sponsored by Care Arthritis.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target
4
Study locations

NCT06454188 is a Phase 4 study of Psoriatic Arthritis and Spondyloarthritis, Axial that is actively recruiting participants, run by Care Arthritis. The registered enrollment target is 100 participants, below the 851-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06454188, a Phase 4 study of Psoriatic Arthritis and Spondyloarthritis, Axial, is actively recruiting participants, sponsored by Care Arthritis.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target
4
Study locations

Study Summary

A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)

Conditions Studied

Psoriatic Arthritis Spondyloarthritis, Axial

Interventions

  • DRUG Placebo
  • DRUG Upadacitinib 15 MG [Rinvoq]

Study Locations (4)

Oregon

  • Oregon Health and Science University - Portland

Texas

  • DM Clinical Research - Tomball

Ontario

  • The Ottawa Hospital Research Institute - Ottawa

Quebec

  • Groupe de Recherche en Maladies Osseuses (G.R.M.O.) Inc. - Québec

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-11-06
Est. Completion 2026-12
Phase Phase 4

Sponsor

Care Arthritis

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06454188

The ClinicalTrials.gov registry entry for NCT06454188 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 851-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (88% lower). The listed sponsor is Care Arthritis, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Psoriatic Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06454188 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Oregon, Texas, Ontario.

Frequently Asked Questions

What is clinical trial NCT06454188 about?

NCT06454188 is a clinical study titled "A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis". A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)

What is the current status of trial NCT06454188?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2024-11-06. Estimated completion is 2026-12.

What conditions does trial NCT06454188 study?

This clinical trial studies the following conditions: Psoriatic Arthritis, Spondyloarthritis, Axial.

What interventions are being tested in trial NCT06454188?

The interventions under investigation include: Placebo (DRUG), Upadacitinib 15 MG [Rinvoq] (DRUG).

Who is sponsoring clinical trial NCT06454188?

This trial is sponsored by Care Arthritis, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06454188 being conducted?

This trial has 4 study locations across Oregon, Texas, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Psoriatic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Psoriatic Arthritis

All registered trials for this condition

Spondyloarthritis, Axial

All registered trials for this condition

Oregon

All trials with a study site in Oregon

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.